Advanced Clinical Research Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 20 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth %
- Profit Growth 13.51%
- Ebitda -10.46%
- Net Worth -198.24%
- Total Assets -31.36%
About Advanced Clinical Research
Advanced Clinical Research Private Limited (ACRPL) is a Private Limited Indian Non-Government Company incorporated in India on 26 March 2004 and has a history of 20 years and 11 months. Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Preeti Lodha and Sreetama Kar serve as directors at the Company.
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51397KA2004PTC033641
- Company No.
033641
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Mar 2004
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Advanced Clinical Research?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Preeti Lodha  | Director | 26-Feb-2021 | Current |
| Sreetama Kar | Additional Director | 11-Dec-2023 | Current |
Financial Performance of Advanced Clinical Research.
Advanced Clinical Research Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 13.51% increase in profit. The company's net worth observed a substantial decline by a decrease of 198.24%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Advanced Clinical Research?
In 2022, Advanced Clinical Research had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Biolitec Meditech India Private LimitedPreeti Lodha and Sreetama Kar are mutual person
Biolitec India Private LimitedPreeti Lodha and Sreetama Kar are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Advanced Clinical Research?
Unlock and access historical data on people associated with Advanced Clinical Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Advanced Clinical Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Advanced Clinical Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
